T. Rowe Price (TROW)
(Delayed Data from NSDQ)
$109.28 USD
-0.34 (-0.31%)
Updated Aug 26, 2024 04:00 PM ET
After-Market: $109.28 0.00 (0.00%) 5:38 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$109.28 USD
-0.34 (-0.31%)
Updated Aug 26, 2024 04:00 PM ET
After-Market: $109.28 0.00 (0.00%) 5:38 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Zacks News
T. Rowe Price (TROW) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
T. Rowe (TROW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What Awaits Principal Financial (PFG) This Earnings Season?
by Zacks Equity Research
Principal Financial (PFG) first-quarter results are likely to reflect lower sales in the pension risk transfer and individual annuities, foreign currency headwinds and higher assets under management.
Fee Income to Aid Regions (RF) Q1 Earnings Amid Low Rates
by Zacks Equity Research
Regions (RF) Q1 earnings are likely to have gained from decent fee income, partly offset by unfavorable impact of lower rates on net interest income.
Will Fee Income Growth Support Huntington (HBAN) Q1 Earnings?
by Zacks Equity Research
Huntington's (HBAN) Q1 earnings are likely to have benefited from improved fee income, partly negated by low rates and high expenses.
This is Why T. Rowe Price (TROW) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does T. Rowe Price (TROW) have what it takes? Let's find out.
Zacks.com featured highlights include: Lockheed Martin, Celanese, Virtu Financial, Polaris and T. Rowe Price
by Zacks Equity Research
Zacks.com featured highlights include: Lockheed Martin, Celanese, Virtu Financial, Polaris and T. Rowe Price
5 ROE Picks as Markets Hit Top Gear With Solid Earnings Start
by Supriyo Bose
Lockheed Martin (LMT), Celanese (CE), Virtu Financial (VIRT), Polaris (PII) and T. Rowe (TROW) are some of the top ROE stocks to buy as markets trade near record highs.
Zacks.com featured highlights include: East West Bancorp, HCA Healthcare, Microsoft and T. Rowe Price
by Zacks Equity Research
Zacks.com featured highlights include: East West Bancorp, HCA Healthcare, Microsoft and T. Rowe Price
Zacks.com featured highlights include: East West Bancorp, HCA Healthcare, Microsoft and T. Rowe Price
by Zacks Equity Research
Zacks.com featured highlights include: East West Bancorp, HCA Healthcare, Microsoft and T. Rowe Price
Screening for Triple Threat Stocks: Value, Growth and Dividends
by Tracey Ryniec
Is it possible for investors to find cheap stocks that have double digit growth and that also pay a great dividend yield?
Will T. Rowe (TROW) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
T. Rowe (TROW) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
4 GARP Stocks for a Winning Portfolio
by Shilpa Mete
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.
T. Rowe Price (TROW) March AUM Sees 1.3% Sequential Growth
by Zacks Equity Research
Diverse business model and the roll-out of new funds are likely to stoke T. Rowe Price's (TROW) AUM growth.
ATCO or TROW: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ATCO vs. TROW: Which Stock Is the Better Value Option?
T. Rowe Price (TROW) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does T. Rowe Price (TROW) have what it takes? Let's find out.
Zacks.com featured highlights include: East West Bancorp, HCA Healthcare, CDW Corp and T. Rowe Price Group
by Zacks Equity Research
Zacks.com featured highlights include: East West Bancorp, HCA Healthcare, CDW Corp and T. Rowe Price Group
4 GARP Stocks to Scoop Up for Maximum Returns
by Zacks Equity Research
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
CBTX Hikes Dividend by 30%: Is the Stock Worth Considering?
by Zacks Equity Research
In a bid to add shareholder value, CBTX announces a 30% increase in its quarterly cash dividend. Investors may consider adding the stock to their portfolio based on dividend income.
JHG or TROW: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
JHG vs. TROW: Which Stock Is the Better Value Option?
Why T. Rowe Price (TROW) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does T. Rowe Price (TROW) have what it takes? Let's find out.
Zacks.com featured highlights include: HCA Healthcare, East West Bancorp, CDW Corp, T. Rowe Price Group and KLA Corp
by Zacks Equity Research
Zacks.com featured highlights include: HCA Healthcare, East West Bancorp, CDW Corp, T. Rowe Price Group and KLA Corp
5 GARP Stocks for a Winning Portfolio
by Shilpa Mete
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.
T. Rowe Price (TROW) Reports 2.7% Growth in February AUM
by Zacks Equity Research
Diverse business model and rollout of new funds are likely to stoke AUM growth of T. Rowe Price (TROW).
Invesco (IVZ) February AUM Up on Favorable Markets & Inflows
by Zacks Equity Research
Invesco (IVZ) witnesses a 1.8% sequential rise in February 2021 AUM.
Franklin (BEN) February AUM Up on Favorable Market Returns
by Zacks Equity Research
Franklin's (LAZ) February AUM rises sequentially on market appreciation and net inflows.